Submitted by Anonymous (not verified) on 24 June 2025 - 16:28
Human medicines European public assessment report (EPAR): Beyonttra, acoramidis, Date of authorisation: 10/02/2025, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Beyonttra, acoramidis, Date of authorisation: 10/02/2025, Revision: 1, Status: Authorised